Clinical Trials
9
Active:0
Completed:5
Trial Phases
2 Phases
Phase 2:8
Phase 4:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (9 trials with phase data)• Click on a phase to view related trials
Phase 2
8 (88.9%)Phase 4
1 (11.1%)A Phase II Study Of Abraxane and Nexavar in the First-Line Treatment of Locally Advanced or Metastatic Breast Cancer
Phase 2
Terminated
- Conditions
- Breast Cancer
- First Posted Date
- 2008-02-05
- Last Posted Date
- 2012-05-11
- Lead Sponsor
- Veeda Oncology
- Target Recruit Count
- 16
- Registration Number
- NCT00607438
- Locations
- 🇺🇸
Veeda Oncology, Columbus, Ohio, United States
A Phase IV Trial of Cesamet™ Given With Standard Antiemetic Therapy for Chemotherapy-induced Nausea and Vomiting
Phase 4
Terminated
- Conditions
- Nausea and Vomiting
- First Posted Date
- 2007-01-05
- Last Posted Date
- 2010-12-02
- Lead Sponsor
- Veeda Oncology
- Target Recruit Count
- 16
- Registration Number
- NCT00418678
- Locations
- 🇺🇸
Veeda Oncology, Columbus, Ohio, United States
PII Trial of Docetaxel/Prednisone w/Sargramostim for HRPC
Phase 2
Terminated
- Conditions
- Hormone Refractory Prostate Cancer
- First Posted Date
- 2006-04-12
- Last Posted Date
- 2012-05-11
- Lead Sponsor
- Veeda Oncology
- Target Recruit Count
- 35
- Registration Number
- NCT00313482
- Locations
- 🇺🇸
Veeda Oncology, Columbus, Ohio, United States
A Phase II Trial of Abraxane™ Given Weekly as a Single Agent in First-line Treatment of Metastatic Breast Cancer
Phase 2
Completed
- Conditions
- Metastatic Breast Cancer
- First Posted Date
- 2005-11-10
- Last Posted Date
- 2012-05-11
- Lead Sponsor
- Veeda Oncology
- Target Recruit Count
- 72
- Registration Number
- NCT00251472
- Locations
- 🇺🇸
Veeda Oncology, Columbus, Ohio, United States
A Phase II Study of Eloxatin and Alimta in Combination With Bevacizumab in Advanced Non-Squamous NSCLC
Phase 2
Completed
- Conditions
- Non-Small Cell Lung Cancer
- First Posted Date
- 2005-11-10
- Last Posted Date
- 2012-05-11
- Lead Sponsor
- Veeda Oncology
- Target Recruit Count
- 69
- Registration Number
- NCT00251524
- Locations
- 🇺🇸
Veeda Oncology, Columbus, Ohio, United States
- Prev
- 1
- 2
- Next
News
No news found